Literature DB >> 26907214

Variations in MHC Class II Antigen Processing and Presentation in Health and Disease.

Emil R Unanue1, Vito Turk2, Jacques Neefjes3,4.   

Abstract

MHC class II (MHC-II) molecules are critical in the control of many immune responses. They are also involved in most autoimmune diseases and other pathologies. Here, we describe the biology of MHC-II and MHC-II variations that affect immune responses. We discuss the classic cell biology of MHC-II and various perturbations. Proteolysis is a major process in the biology of MHC-II, and we describe the various components forming and controlling this endosomal proteolytic machinery. This process ultimately determines the MHC-II-presented peptidome, including cryptic peptides, modified peptides, and other peptides that are relevant in autoimmune responses. MHC-II also variable in expression, glycosylation, and turnover. We illustrate that MHC-II is variable not only in amino acids (polymorphic) but also in its biology, with consequences for both health and disease.

Entities:  

Keywords:  HLA; MHC class II; antigen presentation; autoimmunity; cathepsins; inhibitors; polymorphism; processing

Mesh:

Substances:

Year:  2016        PMID: 26907214     DOI: 10.1146/annurev-immunol-041015-055420

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  68 in total

1.  Developmental exposure to chemicals associated with unconventional oil and gas extraction alters immune homeostasis and viral immunity of the amphibian Xenopus.

Authors:  Jacques Robert; Connor C McGuire; Susan Nagel; B Paige Lawrence; Francisco De Jesús Andino
Journal:  Sci Total Environ       Date:  2019-03-26       Impact factor: 7.963

2.  Improved peptide-MHC class II interaction prediction through integration of eluted ligand and peptide affinity data.

Authors:  Christian Garde; Sri H Ramarathinam; Emma C Jappe; Morten Nielsen; Jens V Kringelum; Thomas Trolle; Anthony W Purcell
Journal:  Immunogenetics       Date:  2019-06-10       Impact factor: 2.846

3.  Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies.

Authors:  Gautam Goel; Tim King; A James Daveson; Jane M Andrews; Janakan Krishnarajah; Richard Krause; Gregor J E Brown; Ronald Fogel; Charles F Barish; Roger Epstein; Timothy P Kinney; Philip B Miner; Jason A Tye-Din; Adam Girardin; Juha Taavela; Alina Popp; John Sidney; Markku Mäki; Kaela E Goldstein; Patrick H Griffin; Suyue Wang; John L Dzuris; Leslie J Williams; Alessandro Sette; Ramnik J Xavier; Ludvig M Sollid; Bana Jabri; Robert P Anderson
Journal:  Lancet Gastroenterol Hepatol       Date:  2017-05-11

Review 4.  Biological Consequences of MHC-II Expression by Tumor Cells in Cancer.

Authors:  Margaret L Axelrod; Rebecca S Cook; Douglas B Johnson; Justin M Balko
Journal:  Clin Cancer Res       Date:  2018-11-21       Impact factor: 12.531

5.  Distinct editing functions of natural HLA-DM allotypes impact antigen presentation and CD4+ T cell activation.

Authors:  Miguel Álvaro-Benito; Eliot Morrison; Friederike Ebner; Esam T Abualrous; Marie Urbicht; Marek Wieczorek; Christian Freund
Journal:  Cell Mol Immunol       Date:  2018-11-22       Impact factor: 11.530

6.  The Human Immunopeptidome Project: A Roadmap to Predict and Treat Immune Diseases.

Authors:  Juan Antonio Vizcaíno; Peter Kubiniok; Kevin A Kovalchik; Qing Ma; Jérôme D Duquette; Ian Mongrain; Eric W Deutsch; Bjoern Peters; Alessandro Sette; Isabelle Sirois; Etienne Caron
Journal:  Mol Cell Proteomics       Date:  2019-11-19       Impact factor: 5.911

Review 7.  ANCA-Associated Vasculitis Pathogenesis: A Commentary.

Authors:  Eric J Gapud; Philip Seo; Brendan Antiochos
Journal:  Curr Rheumatol Rep       Date:  2017-04       Impact factor: 4.592

8.  MHC class II cell-autonomously regulates self-renewal and differentiation of normal and malignant B cells.

Authors:  Julia Merkenschlager; Urszula Eksmond; Luca Danelli; Jan Attig; George R Young; Carla Nowosad; Pavel Tolar; George Kassiotis
Journal:  Blood       Date:  2019-01-30       Impact factor: 22.113

9.  MHC Class II Antigen Presentation by the Intestinal Epithelium Initiates Graft-versus-Host Disease and Is Influenced by the Microbiota.

Authors:  Motoko Koyama; Pamela Mukhopadhyay; Iona S Schuster; Andrea S Henden; Jan Hülsdünker; Antiopi Varelias; Marie Vetizou; Rachel D Kuns; Renee J Robb; Ping Zhang; Bruce R Blazar; Ranjeny Thomas; Jakob Begun; Nicola Waddell; Giorgio Trinchieri; Robert Zeiser; Andrew D Clouston; Mariapia A Degli-Esposti; Geoffrey R Hill
Journal:  Immunity       Date:  2019-09-18       Impact factor: 31.745

Review 10.  Present Yourself! By MHC Class I and MHC Class II Molecules.

Authors:  Kenneth L Rock; Eric Reits; Jacques Neefjes
Journal:  Trends Immunol       Date:  2016-09-07       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.